AFP and neoplasm: Furthermore, We investigated marker capacity for those undergoing tumor resection and noted an extremely high performance of PIVKA-II (AUC = 0.930), AFP + PIVKA-II (AUC = 0.936), and AFP + PIVKA-II + AST models (AUC = 0.966, P = 0.044, Additional file 6: Table S6).